John Patience - May 21, 2024 Form 4 Insider Report for BIODESIX INC (BDSX)

Signature
/s/ Robin H. Cowie as Attorney-in-Fact for John Patience
Stock symbol
BDSX
Transactions as of
May 21, 2024
Transactions value $
$0
Form type
4
Date filed
5/23/2024, 07:12 PM
Previous filing
May 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDSX Common Stock Options Exercise +217K +4.71% 4.83M May 23, 2024 By John Patience Living Trust dated 7/23/1993 F1, F2
holding BDSX Common Stock 338K May 21, 2024 Direct
holding BDSX Common Stock 2.08M May 21, 2024 By Patience Enterprises LP F3
holding BDSX Common Stock 53K May 21, 2024 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDSX Restricted Stock Units Award $0 +46.7K $0.00 46.7K May 21, 2024 Common Stock 46.7K Direct F4, F5
transaction BDSX Stock Options (Right to Buy) Award $0 +37.1K $0.00 37.1K May 21, 2024 Common Stock 37.1K $1.57 Direct F6
transaction BDSX Series A Non-Voting Convertible Preferred Stock Options Exercise $0 -5.44K -100% $0.00* 0 May 23, 2024 Common Stock 217K By John Patience Living Trust dated 7/23/1993 F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") into shares of the Issuer's common stock ("Common Stock") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024.
F2 The Reporting Person is the sole trustee of John Patience Living Trust (July 23, 1993).
F3 The Reporting Person is the sole general partner of Patience Enterprises LP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F4 Each restricted stock unit (the "RSU") represents a contingent right to receive one share of Common Stock.
F5 These RSUs will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period.
F6 This option will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, this option will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period.